Claudius Rudin

Author PubWeight™ 12.65^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial.	Lancet	2010	5.04
2	The role of maintenance thalidomide therapy in multiple myeloma: MRC Myeloma IX results and meta-analysis.	Blood	2011	2.69
3	Effects of zoledronic acid versus clodronic acid on skeletal morbidity in patients with newly diagnosed multiple myeloma (MRC Myeloma IX): secondary outcomes from a randomised controlled trial.	Lancet Oncol	2011	1.71
4	Cyclophosphamide, thalidomide, and dexamethasone (CTD) as initial therapy for patients with multiple myeloma unsuitable for autologous transplantation.	Blood	2011	1.32
5	Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results.	Haematologica	2011	1.32
6	Autologous stem cell transplantation for enteropathy-associated T-cell lymphoma: a retrospective study by the EBMT.	Blood	2013	0.90
7	Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results.	Br J Haematol	2014	0.76
8	Collection of peripheral blood stem cells in new patients with myeloma receiving minimal or no prior cytoreductive therapy.	Hematology	2007	0.75
9	Re-use of the original infusional induction chemotherapy as salvage therapy in myeloma patients relapsing after one autograft.	Hematology	2005	0.75